#1399 The prognostic significance of the Birmingham Vasculitis Activity Score on the outcome of ANCA- associated vasculitis

Abstract Background and Aims Anti-neutrophil cytoplasmic antibody (ANCA) -associated vasculitis (AAV) is related to substantial morbidity and mortality, even with the latest treatments. Renal involvement is common in AAV and the most important mortality predictor. The Birmingham Vasculitis Activity Score (BVAS) has emerged as an essential tool in assessing disease activity and predicting long-term prognosis. The study evaluated the association between BVAS and outcomes in renal vasculitis patients. Method A retrospective study was carried out from 2021 to 2024. Twenty patients (13 women and 7 men) with systemic vasculitis were included in the study. Clinical and laboratory data were collected. The BVAS was evaluated for all the patients. Patients were divided into three groups according to their outcomes: remission, renal replacement therapy (RRT), and nonsurvivors. Results Eight patients had the presence of PR3- ANCA and twelve patients were positive for MPO-ANCA. All patients were presented with impaired renal function. Nine patients made renal remission, three patients needed RRT, and eight patients did not survive. The BVAS ranged from 6 to 22 (mean 13.2 ± 3.6). The mean BVAS in the remission group was 10.89 ± 2.89, in the RRT group 13.00 ± 1.73, and in the nonsurvivors 15.88 ± 3.18. Independent Kruskal- Walli's test showed a significant relationship between groups χ²(2) = 8.724, P = 0.013, but without specifying among which groups. After the Bonferroni adjustment, a significant difference between BVAS in the remission group and nonsurvivors was found, χ²(2) = 8.444, P = 0.009, and no difference between remission and RRT groups, and RRT and nonsurvivors was found. Conclusion These findings indicate that BVAS might be a prognostic indicator of ANCA-associated vasculitis. Moreover, BVAS can contribute to the early identification of high-risk patients requiring more aggressive therapeutic interventions. However, further investigation would be necessary to confirm this hypothesis.

Authors

Institutions

Publication Details

Journal
Nephrology Dialysis Transplantation
Published
2025-10-01
DOI
https://doi.org/10.1093/ndt/gfaf116.1279
Primary Topic
Vasculitis and related conditions
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

#1399 The prognostic significance of the Birmingham Vasculitis Activity Score on the outcome of ANCA- associated vasculitis

Metin Selmani, Erjola Likaj, Ariana Strakosha, Suela Mumajesi et al.
Nephrology Dialysis Transplantation
Vasculitis and related conditions
article

#1399 The prognostic significance of the Birmingham Vasculitis Activity Score on the outcome of ANCA- associated vasculitis

Metin Selmani, Erjola Likaj, Ariana Strakosha, Suela Mumajesi, Merita Rroji, Saimir Seferi, Elena Gjecka
article en

Abstract

Abstract Background and Aims Anti-neutrophil cytoplasmic antibody (ANCA) -associated vasculitis (AAV) is related to substantial morbidity and mortality, even with the latest treatments. Renal involvement is common in AAV and the most important mortality predictor. The Birmingham Vasculitis Activity Score (BVAS) has emerged as an essential tool in assessing disease activity and predicting long-term prognosis. The study evaluated the association between BVAS and outcomes in renal vasculitis patients. Method A retrospective study was carried out from 2021 to 2024. Twenty patients (13 women and 7 men) with systemic vasculitis were included in the study. Clinical and laboratory data were collected. The BVAS was evaluated for all the patients. Patients were divided into three groups according to their outcomes: remission, renal replacement therapy (RRT), and nonsurvivors. Results Eight patients had the presence of PR3- ANCA and twelve patients were positive for MPO-ANCA. All patients were presented with impaired renal function. Nine patients made renal remission, three patients needed RRT, and eight patients did not survive. The BVAS ranged from 6 to 22 (mean 13.2 ± 3.6). The mean BVAS in the remission group was 10.89 ± 2.89, in the RRT group 13.00 ± 1.73, and in the nonsurvivors 15.88 ± 3.18. Independent Kruskal- Walli's test showed a significant relationship between groups χ²(2) = 8.724, P = 0.013, but without specifying among which groups. After the Bonferroni adjustment, a significant difference between BVAS in the remission group and nonsurvivors was found, χ²(2) = 8.444, P = 0.009, and no difference between remission and RRT groups, and RRT and nonsurvivors was found. Conclusion These findings indicate that BVAS might be a prognostic indicator of ANCA-associated vasculitis. Moreover, BVAS can contribute to the early identification of high-risk patients requiring more aggressive therapeutic interventions. However, further investigation would be necessary to confirm this hypothesis.

Nephrology Dialysis TransplantationVol. 40(Supplement_3)
Mother Teresa Hospital (AL)
Openalex Percentile: Top 57%
Vasculitis and related conditions
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.